Oxford Haemato-Oncology Service (Oxford University Hospitals NHS Foundation Trust)
General information
Oxford Haemato-Oncology Service
Oxford University Hospitals NHS Foundation Trust
Level 4, John Radcliffe Hospital, Headley Way
Oxford
Oxfordshire
United Kingdom - OX3 9DU
http://www.oxford-translational-molecular-diagnostics.org.uk/content/molecular-haemato-oncology
Organization ID: 506072
Oxford University Hospitals NHS Foundation Trust
Level 4, John Radcliffe Hospital, Headley Way
Oxford
Oxfordshire
United Kingdom - OX3 9DU
http://www.oxford-translational-molecular-diagnostics.org.uk/content/molecular-haemato-oncology
Organization ID: 506072
Personnel
- Helene DREAU, Lab Director
Phone: 0041865223190
Email: helene.dreau@ouh.nhs.uk
Assertion criteria
Level: Assertion criteria not provided
Summary of submissions to ClinVar
Total submissions: 32
Gene
Gene | Submissions | Last Updated |
---|---|---|
ARID1A | 1 | Feb 5, 2018 |
BRCA2 | 2 | Feb 5, 2018 |
CDKN2A | 3 | Feb 5, 2018 |
CSDE1 | 1 | Feb 5, 2018 |
DDX3X | 1 | Feb 5, 2018 |
ERCC3 | 1 | Feb 5, 2018 |
FANCA | 2 | Feb 5, 2018 |
HDAC2 | 1 | Feb 5, 2018 |
NF1 | 1 | Feb 5, 2018 |
NFE2L2 | 1 | Feb 5, 2018 |
NRAS | 1 | Feb 5, 2018 |
PIK3CA | 1 | Feb 5, 2018 |
POLE | 2 | Feb 5, 2018 |
PTEN | 3 | Feb 5, 2018 |
RAD51B | 2 | Feb 5, 2018 |
SETD2 | 1 | Feb 5, 2018 |
SMAD4 | 1 | Feb 5, 2018 |
TP53 | 6 | Feb 5, 2018 |
TSC1 | 1 | Feb 5, 2018 |
Condition
Name | Submissions | Last Updated |
---|---|---|
AKT1 Inhibitor response | 1 | Feb 5, 2018 |
Colorectal cancer | 2 | Feb 5, 2018 |
Histone Methylation Therapy response | 1 | Feb 5, 2018 |
Mitogen-activated protein kinase kinase inhibitor response | 1 | Feb 5, 2018 |
Poly (ADP-Ribose) polymerase inhibitor response | 18 | Feb 5, 2018 |
Programmed death ligand-1 (PD-L1) blocking antibody response | 2 | Feb 5, 2018 |
Ras Inhibitor response | 1 | Feb 5, 2018 |
Vascular endothelial growth factor (VEGF) inhibitor response | 3 | Feb 5, 2018 |
Wee1 Inhibitor response | 1 | Feb 5, 2018 |
mTOR Inhibitor response | 2 | Feb 5, 2018 |